226 related articles for article (PubMed ID: 29220885)
1. Indexes of the erythropoietin level in the blood plasma of chronic heart failure patients with anemia.
Zahidova KK
J Basic Clin Physiol Pharmacol; 2018 Jan; 29(1):11-17. PubMed ID: 29220885
[TBL] [Abstract][Full Text] [Related]
2. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study.
Silverberg DS; Wexler D; Sheps D; Blum M; Keren G; Baruch R; Schwartz D; Yachnin T; Steinbruch S; Shapira I; Laniado S; Iaina A
J Am Coll Cardiol; 2001 Jun; 37(7):1775-80. PubMed ID: 11401110
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between concentration of pathological cytokines and erythropoietin in patients with chronic heart failure with anemic syndrome].
Zakhidova KKh
Vestn Ross Akad Med Nauk; 2014; (1-2):32-7. PubMed ID: 25055558
[TBL] [Abstract][Full Text] [Related]
4. [Selection of Optimal Therapy at Correction of the Anemic Syndrome in Patients With Chronic Heart Failure].
Zahidova KK
Kardiologiia; 2018 Jan; (1):25-31. PubMed ID: 29466169
[TBL] [Abstract][Full Text] [Related]
5. The interaction between heart failure and other heart diseases, renal failure, and anemia.
Silverberg DS; Wexler D; Iaina A; Schwartz D
Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure.
van der Meer P; Voors AA; Lipsic E; Smilde TD; van Gilst WH; van Veldhuisen DJ
J Am Coll Cardiol; 2004 Jul; 44(1):63-7. PubMed ID: 15234408
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
[TBL] [Abstract][Full Text] [Related]
8. Serum erythropoietin in heart failure patients treated with ACE-inhibitors or AT(1) antagonists.
Chatterjee B; Nydegger UE; Mohacsi P
Eur J Heart Fail; 2000 Dec; 2(4):393-8. PubMed ID: 11113716
[TBL] [Abstract][Full Text] [Related]
9. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients.
Kuriyama S; Tomonari H; Yoshida H; Hashimoto T; Kawaguchi Y; Sakai O
Nephron; 1997; 77(2):176-85. PubMed ID: 9346384
[TBL] [Abstract][Full Text] [Related]
10. Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists.
Silverberg DS; Wexler D; Iaina A; Steinbruch S; Wollman Y; Schwartz D
Int Urol Nephrol; 2006; 38(2):295-310. PubMed ID: 16868702
[TBL] [Abstract][Full Text] [Related]
11. Anemia in kidney transplants without erythropoietic agents: levels of erythropoietin and iron parameters.
Florit EA; Hadad F; Rodriguez Cubillo B; De la Flor JC; Valga F; Perez Flores I; Calvo Romero N; Valero San Cecilio R; Barrientos Guzman A; Sanchez Fructuoso A
Transplant Proc; 2012 Nov; 44(9):2590-2. PubMed ID: 23146464
[TBL] [Abstract][Full Text] [Related]
12. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron?
Silverberg DS; Wexler D; Iaina A
J Nephrol; 2004; 17(6):749-61. PubMed ID: 15593047
[TBL] [Abstract][Full Text] [Related]
13. A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes.
Comín-Colet J; Ruiz S; Cladellas M; Rizzo M; Torres A; Bruguera J
J Card Fail; 2009 Nov; 15(9):727-35. PubMed ID: 19879457
[TBL] [Abstract][Full Text] [Related]
14. Effects of optimized heart failure therapy and anemia correction with epoetin beta on left ventricular mass in hemodialysis patients.
Hampl H; Hennig L; Rosenberger C; Amirkhalily M; Gogoll L; Riedel E; Scherhag A
Am J Nephrol; 2005; 25(3):211-20. PubMed ID: 15900093
[TBL] [Abstract][Full Text] [Related]
15. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.
Silverberg DS; Wexler D; Blum M; Keren G; Sheps D; Leibovitch E; Brosh D; Laniado S; Schwartz D; Yachnin T; Shapira I; Gavish D; Baruch R; Koifman B; Kaplan C; Steinbruch S; Iaina A
J Am Coll Cardiol; 2000 Jun; 35(7):1737-44. PubMed ID: 10841219
[TBL] [Abstract][Full Text] [Related]
16. The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron.
Silverberg DS; Wexler D; Blum M; Tchebiner JZ; Sheps D; Keren G; Schwartz D; Baruch R; Yachnin T; Shaked M; Schwartz I; Steinbruch S; Iaina A
Nephrol Dial Transplant; 2003 Jan; 18(1):141-6. PubMed ID: 12480972
[TBL] [Abstract][Full Text] [Related]
17. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
Pfisterer M; Buser P; Rickli H; Gutmann M; Erne P; Rickenbacher P; Vuillomenet A; Jeker U; Dubach P; Beer H; Yoon SI; Suter T; Osterhues HH; Schieber MM; Hilti P; Schindler R; Brunner-La Rocca HP;
JAMA; 2009 Jan; 301(4):383-92. PubMed ID: 19176440
[TBL] [Abstract][Full Text] [Related]
18. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure.
Bolger AP; Bartlett FR; Penston HS; O'Leary J; Pollock N; Kaprielian R; Chapman CM
J Am Coll Cardiol; 2006 Sep; 48(6):1225-7. PubMed ID: 16979010
[TBL] [Abstract][Full Text] [Related]
19. Determinants of red cell distribution width (RDW) in cardiorenal patients: RDW is not related to erythropoietin resistance.
Emans ME; van der Putten K; van Rooijen KL; Kraaijenhagen RJ; Swinkels D; van Solinge WW; Cramer MJ; Doevendans PA; Braam B; Gaillard CA
J Card Fail; 2011 Aug; 17(8):626-33. PubMed ID: 21807323
[TBL] [Abstract][Full Text] [Related]
20. Effect of correction of anemia with erythropoietin and intravenous iron in resistant heart failure in octogenarians.
Silverberg DS; Wexler D; Blum M; Schwartz D; Keren G; Sheps D; Iaina A
Isr Med Assoc J; 2003 May; 5(5):337-9. PubMed ID: 12811950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
